145 related articles for article (PubMed ID: 9023642)
41. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.
Annaloro C; Oriana A; Tagliaferri E; Bertolli V; Della Volpe A; Soligo D; Ibatici A; Pozzoli E; Lambertenghi Deliliers GL
Haematologica; 1995; 80(6):512-7. PubMed ID: 8647515
[TBL] [Abstract][Full Text] [Related]
42. The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
Ito Y; Ohyashiki K; Yoshida I; Takeuchi M; Aoyama Y; Mugitani A; Matsuura Y; Wakita H; Matsuda M; Sakamoto E; Kiguchi T; Urabe A; Tamura K; Kanamaru A; Masaoka T
Int J Hematol; 2007 Feb; 85(2):121-7. PubMed ID: 17321989
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study.
Vreugdenhil G; Van Dijke BJ; Donnelly JP; Novakova IR; Raemaekers JM; Hoogkamp-Korstanje MA; Koster M; de Pauw BE
Leuk Lymphoma; 1993 Nov; 11(5-6):353-8. PubMed ID: 8124207
[TBL] [Abstract][Full Text] [Related]
44. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
McKinsey DS; Wheat LJ; Cloud GA; Pierce M; Black JR; Bamberger DM; Goldman M; Thomas CJ; Gutsch HM; Moskovitz B; Dismukes WE; Kauffman CA
Clin Infect Dis; 1999 May; 28(5):1049-56. PubMed ID: 10452633
[TBL] [Abstract][Full Text] [Related]
45. [Antifungal prophylaxis in neutropenic patients].
Cornely OA; Ullmann AJ; Karthaus M
Wien Med Wochenschr; 2001; 151(3-4):73-9. PubMed ID: 11789422
[TBL] [Abstract][Full Text] [Related]
46. Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patients.
Lamy T; Bernard M; Courtois A; Jacquelinet C; Chevrier S; Dauriac C; Grulois I; Guiguen C; Le Prise PY
Leuk Lymphoma; 1998 Jun; 30(1-2):163-74. PubMed ID: 9669686
[TBL] [Abstract][Full Text] [Related]
47. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
48. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
[TBL] [Abstract][Full Text] [Related]
49. A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection.
Smith DE; Bell J; Johnson M; Youle M; Gazzard B; Tchamouroff S; Frechette G; Schlech W; Miller S; Spencer D; Seifert W; Peeters M; De Beule K;
HIV Med; 2001 Apr; 2(2):78-83. PubMed ID: 11737382
[TBL] [Abstract][Full Text] [Related]
50. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients.
Böhme A; Hoelzer D
Mycoses; 1996; 39(11-12):419-26. PubMed ID: 9144997
[TBL] [Abstract][Full Text] [Related]
51. Role of itraconazole in haematology/oncology.
Pandya NA; Atra AA; Riley U; Pinkerton CR
Arch Dis Child; 2003 Mar; 88(3):258-60. PubMed ID: 12598396
[TBL] [Abstract][Full Text] [Related]
52. Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.
Vandewoude K; Vogelaers D; Decruyenaere J; Jaqmin P; De Beule K; Van Peer A; Woestenborghs R; Groen K; Colardyn F
Antimicrob Agents Chemother; 1997 Dec; 41(12):2714-8. PubMed ID: 9420044
[TBL] [Abstract][Full Text] [Related]
53. Prophylaxis of fungal infections with itraconazole during remission-induction therapy.
Prentice AG; Bradford GR
Mycoses; 1989; 32 Suppl 1():96-102. PubMed ID: 2561190
[TBL] [Abstract][Full Text] [Related]
54. Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
Chryssanthou E; Cherif H; Petrini B; Kalin M; Björkholm M
Scand J Infect Dis; 2004; 36(11-12):855-9. PubMed ID: 15764173
[TBL] [Abstract][Full Text] [Related]
55. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
Rimek D; Redetzke K; Kappe R
Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
[TBL] [Abstract][Full Text] [Related]
56. Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.
de Repentigny L; Ratelle J; Leclerc JM; Cornu G; Sokal EM; Jacqmin P; De Beule K
Antimicrob Agents Chemother; 1998 Feb; 42(2):404-8. PubMed ID: 9527794
[TBL] [Abstract][Full Text] [Related]
57. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.
Chariyalertsak S; Supparatpinyo K; Sirisanthana T; Nelson KE
Clin Infect Dis; 2002 Jan; 34(2):277-84. PubMed ID: 11740718
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.
Vehreschild JJ; Sieniawski M; Reuter S; Arenz D; Reichert D; Maertens J; Böhme A; Silling G; Martino R; Maschmeyer G; Rüping MJ; Ullmann AJ; Cornely OA
Int J Antimicrob Agents; 2009 Nov; 34(5):446-50. PubMed ID: 19700265
[TBL] [Abstract][Full Text] [Related]
59. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia.
Prentice AG; Warnock DW; Johnson SA; Taylor PC; Oliver DA
J Antimicrob Chemother; 1995 Oct; 36(4):657-63. PubMed ID: 8591940
[TBL] [Abstract][Full Text] [Related]
60. Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole.
Kanda Y; Kami M; Matsuyama T; Mitani K; Chiba S; Yazaki Y; Hirai H
Hematol Oncol; 1998 Mar; 16(1):33-7. PubMed ID: 9821410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
